SWOG clinical trial number
S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma

100% Accrual
Accrual
100%
Closed
Phase
100% Accrual
Accrual
100%
Published
Abbreviated Title
Phase II MLN8237 in Peripheral T-Cell NHL
Activated
10/28/2011
Closed
06/06/2013
Participants

Research committees

Lymphoma

Treatment

MLN8237

Other Clinical Trials

S2308
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Activated
08/01/2024
22% Accrual
Accrual
22%
Open
Phase
CTSU/AHOD2131
SWOG Clinical Trial Number